Advance of structural modification of nucleosides scaffold.

Xia Lin, Chunxian Liang, Lianjia Zou, Yanchun Yin, Jianyi Wang, Dandan Chen, Weisen Lan

European journal of medicinal chemistry 2021 Mar 15

filter terms:

With Remdesivir being approved by FDA as a drug for the treatment of Corona Virus Disease 2019 (COVID-19), nucleoside drugs have once again received widespread attention in the medical community. Herein, we summarized modification of traditional nucleoside framework (sugar + base), traizole nucleosides, nucleoside analogues assembled by other drugs, macromolecule-modified nucleosides, and their bioactivity rules. 2'-"Ara"-substituted by -F or -CN group, and 3'-"ara" substituted by acetylenyl group can greatly influence their anti-tumor activities. Dideoxy dehydrogenation of 2',3'-sites can enhance antiviral efficiencies. Acyclic nucleosides and L-type nucleosides mainly represented antiviral capabilities. 5-F Substituted uracil analogues exihibit anti-tumor effects, and the substrates substituted by -I, -CF3, bromovinyl group usually show antiviral activities. The sugar coupled with 1-N of triazolid usually displays anti-tumor efficiencies, while the sugar coupled with 2-N of triazolid mainly represents antiviral activities. The nucleoside analogues assembled by cholesterol, polyethylene glycol, fatty acid and phospholipid would improve their bioavailabilities and bioactivities, or reduce their toxicities. Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Citation

Xia Lin, Chunxian Liang, Lianjia Zou, Yanchun Yin, Jianyi Wang, Dandan Chen, Weisen Lan. Advance of structural modification of nucleosides scaffold. European journal of medicinal chemistry. 2021 Mar 15;214:113233